Synthesis of a Novel Surface Active, Light Sensitive Polymer for Encapsulation and Delivery of Paclitaxel by Pillai, Amit Raviraj
University of Mississippi 
eGrove 
Electronic Theses and Dissertations Graduate School 
2019 
Synthesis of a Novel Surface Active, Light Sensitive Polymer for 
Encapsulation and Delivery of Paclitaxel 
Amit Raviraj Pillai 
University of Mississippi 
Follow this and additional works at: https://egrove.olemiss.edu/etd 
 Part of the Pharmacy and Pharmaceutical Sciences Commons 
Recommended Citation 
Pillai, Amit Raviraj, "Synthesis of a Novel Surface Active, Light Sensitive Polymer for Encapsulation and 
Delivery of Paclitaxel" (2019). Electronic Theses and Dissertations. 1675. 
https://egrove.olemiss.edu/etd/1675 
This Thesis is brought to you for free and open access by the Graduate School at eGrove. It has been accepted for 
inclusion in Electronic Theses and Dissertations by an authorized administrator of eGrove. For more information, 
please contact egrove@olemiss.edu. 
“SYNTHESIS OF A NOVEL SURFACE ACTIVE, LIGHT SENSITIVE POLYMER FOR 




Presented for the 
Master of Science  
Pharmaceutical sciences emphasis Pharmaceutics and Drug delivery 
Degree 






















































Melanoma and non-melanoma (basal cell and squamous cell carcinoma) skin cancer (NMSC) have 
been recognized as an epidemic as they happen to be the most common type of cancers in the white 
population. Cancer cell targeting i.e. differentiating cancer cells from normal cells has been an 
area of active research to reduce the side effects of cancer chemotherapy. For this research project, 
we have developed a novel light sensitive Methylene Blue (MB)-Polyethylene glycol (PEG) 
conjugate with significant surfactant properties. The aim of this study was to synthesize a smart 
light sensitive polymer which activates and releases the encapsulated drug on exposure to Near 
Infrared radiation (NIR). This activation of the drug delivery systems on exposure to external 
stimuli can find applications in targeted therapy and diagnosis of NMSC. The synthesis of this 
novel conjugate is a six-step process conducted in a controlled environment with established 
protocols. The synthesized intermediates and final products were subjected to NMR 
characterizations and presumed structures were confirmed with the same. The final structure was 
confirmed with 1H-NMR and FT-IR characterizations. After synthesizing the conjugate, we 
subjected it to NIR radiation to evaluate its light sensitivity. We determined the surface activity 
and critical micellar concentration (CMC) of the conjugate using tensiometry. The micelle forming 
capability of the conjugate was used to encapsulate a model chemotherapeutic agent i.e. Paclitaxel. 
The micelles were characterized based on their loading efficiency, encapsulation efficiency and in 
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CHAPTER I: INTRODUCTION 
Epidemiological evaluation of twenty large regions of the world in 2012 suggested 14.1 million 
new cases and 8.2 million deaths attributed to cancer and this number has only increased since 
then[1][6]. Cancer is a genetic disease which results from genetic mutation or in simpler words 
change in the genetic makeup which controls normal functioning of the cell, specifically growth 
and division[19]. Cancer cells have the capability of manipulating and influencing the molecules, 
normal cells and blood vessels surrounding and feeding the tumor also known as the tumor 
microenvironment[19]. With their capabilities of hiding from the immune response and acquiring 
all the resources required for feeding the tumor, cancer chemotherapy requires targeting. For the 
longest time the Enhanced Permeability and Retention (EPR) effect in tumors had stood as one of 
the fundamental principles of cancer drug delivery, holding the promise of safe, simple and 
effective therapy by allowing nanoparticles preferential access to tumors by virtue of size and 
longevity in circulation[3][4]. Though this rationale seemed well justified by the preclinical evidence 
and the clinical success of Doxil®, recent clinical investigations have suggested that EPR effect is 
not as reliable as previously thought[3]. This failure of EPR effect in clinical trials is attributed to 
the large number of variables in the tumor microenvironment such as the tumor size, interstitial 
fluid pressure (IFP), irregular vascular tissue distribution and poor blood flow inside the tumors. 
Hence, it is suggested to exploit the EPR effect on a case-by-case-basis[3][4][14].  
Clinical failure of EPR effect led to the discovery of specific cancer targeting mechanisms such as 
employing biomarkers (peptides and proteins) which provide high specificity[20] but struggle 
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with stability and potential immunogenicity[17]. Exploiting the characteristics of the tumor 
microenvironment is another potential targeting alternative as the tumor microenvironment has an 
acidic characteristic pH[16], high levels of Reactive Oxygen Species (ROS)[2] and hence increased 
levels of biological antioxidants and enzymes like glutathione peroxidase which can be exploited 
for targeting[22]. Recently, extensive research on employing physical stimuli such as heat[21], 
electrical stimuli[17], light[18] and magnetic stimuli[5][7] for cancer targeting have been explored as 
these mechanisms eliminate the risk of premature release and provide the benefit of specific 
targeting. For this research project Polyethylene Glycol (Methyl Ether) was modified by 
conjugating it with methylene blue. This induces self-assembling properties to the conjugate for 
drug encapsulation, light sensitivity on exposure to N-IR radiation (which penetrates to deep 
tissues)[23] and sensitivity to ROS which stimulates drug release by the breakdown of the 
nanocarrier.  
 
Figure 1. Structure of POEM. 
A moiety with light sensitivity and surfactant property can be used to load potent, water insoluble 
chemotherapeutic agents[9][12] and the release of these agents can be facilitated by exposure of light 
over the tumor. Light sensitive nanoparticles can be used extensively for the treatment of 
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Melanoma and Non-Melanoma (basal cell and squamous cell carcinoma) skin cancer (NMSC). 
 
Figure 2. Release of MB from POEM on exposure to UV, N-IR and ROS. 
The synthesis of this light sensitive conjugate with surface activity consists of three major steps 
i.e. conjugating the linker (octamethylene diamine) with polyethylene glycol (methyl ether), 
synthesis of activated methylene blue conjugated with ethanolamine and finally conjugating the 
PEG-Linker with activated methylene blue-ethanolamine conjugate.  
The first step of this synthesis (PEG-Linker) involves activation of PEG using 4-Nitrophenyl 
chloroformate[11]. This PEG resin activation is conducted at room temperature in the presence of 
an amine base which leads to a nucleophilic substitution reaction with the release of hydrochloric 
acid (HCl) as a byproduct. This activated PEG is then conjugated with octamethylene diamine 
(linker) through aminolysis of the carbonate group with nitrophenol as a byproduct as shown in 
the reaction mechanism scheme below. The PEG-Linker is the first reactant for the final synthetic 
phase. 
The second step involves conjugation of methylene blue with ethanolamine and activating this 
conjugate using NPC[8][11]. Firstly, methylene blue is reduced to leuco-methylene blue which is 
colorless using sodium dithionite (reducing agent). Leuco-methylene blue is then activated using 
4-NPC by nucleophilic substitution reaction. The amide moiety is converted into carbamide by 
aminolysis induced by ethanolamine with nitrophenol released as a byproduct. The synthesized 
MB-EA is again activated using 4-NPC. The hydroxyl group present at the terminal end of MB-
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EA is activated to MB-EA-NPC by a nucleophilic substitution reaction with HCl as a byproduct. 
MB-EA-NPC is the second reactant for the final synthetic phase. 
Finally, PEG-Linker is reacted with MB-EA-NPC which leads to the aminolytic cleavage of the 
carbonate group at room temperature. This leads to the synthesis of Polyethylene Glycol-
Octamethylene diamine-Ethanolamine-Methylene blue (PEG-Linker-EA-MB) with nitrophenol as 
a byproduct. The structure can be divided into two regions hydrophilic and hydrophobic. Where 
the polyethylene glycol chain is extremely hydrophilic, and Linker-EA-MB is hydrophobic. This 




CHAPTER II: METHODOLOGY 
Materials  
Methylene blue (MB), 4-Nitrophenyl chloroformate (NPC), Ethanolamine (EA), Poly (Ethylene 
glycol) Methyl Ether 2000, Octamethylene Diamine, Paclitaxel, Triethylamine, Sodium sulphate, 
Sodium bicarbonate, Sodium carbonate, Hydrochloric acid, Sodium chloride, Toluene, Dichloro 
methane, Acetonitrile, Acetone, Tetrahydrofuran, Diethyl ether, Ethyl acetate, Methanol, 
Deionized water, Hexane, Activated silica gel, Sand, Sodium salicylate. 
Methods 
Synthesis of Polyethylene Glycol (PEG)-Octamethylene diamine (Linker) 
The PEG-Linker was synthesized in two steps i.e. activation of PEG using 4-nitrophenyl 
chloroformate (NPC) and then conjugating octamethylene diamine on the activated PEG. 
 
Figure 3.   Schematic representation of the synthesis of PEG-Linker (1) Activation of PEG 2000 
(2) Conjugation of the linker with activated PEG 2000.
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Activation of PEG 
5g of PEG 2000 was dissolved in 50 ml of toluene with heating. The PEG was dried using a Dean-
Stark tube with reflux by increasing the temperature from 60C to 120C. Bringing the volume as 
low as 10 ml to this 10 ml of dichloromethane (DCM) was added. This mixture was transferred to 
a round bottom flask (RBF). Excess NPC (five times the quantity if PEG 2000) was dissolved in 
minimal quantity of DCM and using a dropper, NPC was added into the RBF. Triethylamine 
(TEA) was added to the RBF to provide basicity to the solution. The reaction was conducted for 
12 hours at room temperature and the progress of the reaction was monitored using TLC plates. 
Once the reaction was complete, the product was subjected to purification by adding the solution 
of the crude product into a flask containing cold diethyl ether with continuous stirring for 45 
minutes (amount of diethyl ether was taken in excess). The precipitated PEG-NPC was again 
subjected to purification by precipitation using diethyl ether twice before drying it. The dried 
precipitates were recrystallized using ethyl acetate. The dried PEG-NPC was characterized using 
1H NMR. 
Conjugation of activated PEG with Octamethylene diamine 
Excess linker was dissolved in 2 ml of methanol and then volume was adjusted up to 10 ml with 
DCM. To this solution TEA was added to maintain basic reaction conditions. PEG-NPC (activated 
PEG) was dissolved in 10 ml of DCM and then added dropwise into the RBF containing the linker 
solution. The reaction was conducted at room temperature for 12 hours and the progress of the 
reaction was checked using TLC plates. The final product was purified using an excess of cold 
diethyl ether and the precipitate was subjected to purification by precipitation two times before 




Synthesis of Methylene Blue (MB)-Ethanolamine (Linker)-4 Nitrophenyl chloroformate 
(Activator) 
The hydrophobic part of the surfactant backbone was prepared by conjugation of methylene blue 
with ethanolamine. This was performed in three steps i.e. activation of MB using 4-nitrophenyl 
chloroformate (NPC), conjugation of activated MB with ethanolamine and finally activation of 
MB-EA using NP. 
 
Figure 4. Synthesis of activated MB-EA (1) activation of MB (2) Cojugation of MB with EA (3) 
Activation of MB-EA 
 
Activation of Methylene blue using 4-Nitrophenyl chloroformate  
2 g methylene blue was dissolved in 50 ml of de-ionized water using acetone and then heated at 
50 ºC (to evaporate acetone) to this 125 ml of toluene and quantity sufficient sodium dithionite 
was added until the organic layer becomes clear (methylene blue is converted to leuco-methylene 
blue). The organic layer is then transferred to an RBF with sodium sulphate using canula transfer 
to prevent oxidation of the leuco-methylene blue. Once the moisture is removed from the organic 
layer, it is transferred to an RBF with 1.8 g NPC dissolved in sufficient quantity of toluene and the 
reaction was propagated at 50 ºC for 15 minutes, TEA was used to induce basic conditions to the 
reaction. The reaction mixture was filtered and washed thrice using base (saturated sodium 
bicarbonate solution), thrice using acid (0.1 N HCl) and once with brine (Saturated solution of 
sodium chloride). Water was removed using Sodium sulphate and the reaction mixture was 
filtered. The filtrate was exposed to rotating vacuum evaporator to remove toluene from the 
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reaction mixture. The crude produce was recrystallized with acetonitrile, filtered, dried and stored 
for further use. The crude product was characterized using 1H NMR. Activated MB was directly 
conjugated  to PEG-Linker to before introducing ethanolamine and characterized for its surface 
activity. 
Conjugation of activated methylene blue with ethanolamine 
MB-NP (450 mg, 1.0 mmol) was dissolved in anhydrous THF (15 ml, with heating to speed up the 
dissolution rate) yielding yellow/golden solution. The solution was added dropwise into 10 ml 
THF containing ethanolamine (620 mg, 11.11 mmol) and triethylamine. The reaction mixture was 
protected from light and refluxed at 60oC for 1 day and the reaction progress was checked using 
TLC. The THF was removed using the rotating vacuum evaporator and the crude product was 
dissolved in DCM. This solution was exposed to washing 3 times with NaHCO3 and water. The 
obtained organic phase was dried using sodium sulphate and evaporated under reduced pressure 
and subjected to flash column chromatography (hexane: ethyl acetate; 1:1). When all the impurities 
were eluted out (monitored using TLC), 100% acetone was used as the mobile phase to elute out 
MB-EA. The acetone was removed using the rotary vacuum evaporator and the product was dried 
and characterized using 1H NMR.  
Activation of MB-EA with 4-Nitophenyl chloroformate 
Nitrophenyl chloroformate (400 mg, 2.0 mmol) was dissolved in DCM and the cooled MB-EA 
(350 mg, 1.0 mmol) solution was prepared in DCM simultaneously. NPC in DCM was added 
dropwise to the MB-EA solution in a round bottom flask on an ice bath. The RBF was removed 
from the ice bath after 30 minutes and the reaction was propagated at room temperature for 12 
hours (the progress of the reaction was checked using TLC plates). The reaction mixture was 
washed with NaHCO3 and water. The collected organic phase was dried to 1 ml volume and 
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subjected to flash column chromatography using (Hexane: Ethyl acetate; 2:1) until all the  
impurities were removed. Ethyl acetate was used to elute MB-EA-NP (activated MB-EA). The 
eluted solution was evaporated under reduced pressure yielding a light brown product which was 
characterized using 1H NMR. 
Synthesis of Polyethylene Glycol (PEG)-Octamethylene diamine-Methylene Blue (MB) & 
Polyethylene Glycol (PEG)-Octamethylene diamine-Ethanolamine-Methylene Blue (MB) 
PEG-Linker and triethyl amine were dissolved in DCM and transferred to a round bottom flask. 
Activated MB/MB-EA were dissolved in DCM and added dropwise to the RBF with constant 
stirring. The final product was purified using excess cold diethyl ether and the precipitate was 
subjected to purification by precipitation two times before drying. The dried product was 
recrystallized using ethyl acetate and then characterized using 1H NMR. 
 
Figure 5. Synthesis of POEM by conjugation of PEG-Linker with activated MB-EA. 
Determination of light sensitivity by NIR irradiation  
To confirm the sensitivity of the product to NIR radiation, the fluorescence of methylene blue 
was used as an indicator. The first step of this experiment was to irradiate and the second step 
was spectroscopic detection. 
Irradiation procedures 
A LumaCare® LC-122A equipped with 24W halogen lamp (non-coherent light source) and a 660 
nm optic fiber probe with 325 mW/cm2 light intensity at the fiber tip was used for all NIR 
irradiation experiments. The light intensity at the irradiated samples surface was estimated based 
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on the distance from the fiber tip to the sample, using a non-public-distribution excel worksheet 
provided by LumaCare Medical Group. Normally, a 25.42 mm distance from tip will be subjected 
to a 25 mW/cm2 incident light intensity. An Ultra-LUM UV crosslinker chamber, model AEX-
800 was used for all UV irradiation experiments. The 6 x 6-watt mercury lamps mounted on the 
ceiling emits 365 nm wavelength light. The intensity of light inside the chamber varied from 1.5 
to 2.0 mW/cm2 during the operating time. 
Fluorescence and absorbance spectral measurements 
Fluorescence measurements were performed using a LC500 Perkin Elmer fluorescence 
spectrophotometer at 660 nm excitation wavelength, 600 to 800 nm emission wavelength, 10 nm 
excitation slit and 10 nm emission slit. MB derivatives were completely dissolved and diluted in a 
solvent mixture of acetone: 1 µM pH 7.4 phosphate buffer 70:30 unless otherwise stated. The 
sample concentration was kept below 15 µM to guarantee the linear relationship between 
fluorescence intensity, MB concentration and minimize MB aggregation. Exactly 1 ml of the tested 
solution is loaded into fluorescence cell and sealed with a paraffin film to prevent solvent 
evaporation during the irradiation process. Absorbance scans were performed using a Genesys 8 
UV-VIS spectrophotometer. The sample’s concentration was kept at around 50 µM since the 
detection sensitivity of absorbance method is lower than that of fluorescence.  
Determination of Sensitivity to Reactive Oxygen Species (ROS) 
Determination of sensitivity to ROS was conducted by preparing aqueous polymeric solution and 
exposing it to three conditions i.e. H2O2, H2O2+Fe(II), H2O2+Peroxidase. For this experiment a 10 
mM solution of H2O2, 10 mM solution of FeSO4, 500 µg/ml solution of the synthesized polymer 
and 10 µg/ml of Peroxidase enzyme were prepared. The reaction vials with the composition shown 
in Table 1 were prepared and stored in the dark for four days. The release was observed using UV-
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Visible spectroscopic measurement. Absorbance was measured at 666 nm in the UV-Visible 
Spectrophotometer. 
Table 1. Vial compositions for the ROS sensitivity study. 
*Vial Code Polymeric solution 
(500 µl) 
H2O2 (10 µl) Fe(II) (10 µl) Peroxidase 
(10µl)  
1(a) *    
1(b) *    
1(c) *    
1(d) *    
2(a) * *   
2(b)  * *   
2(c) * *   
2(d) * *   
3(a) * * *  
3(b) * * *  
3(c) * * *  
3(d) * * *  
4 * *  * 
5  *   
6  * *  
7  *  * 
*Volume adjusted to 1 ml using DI water. 
Thermal  characterization 
Thermal properties of a surfactant are important and can be exploited for the development of 
formulations and selection of manufacturing processes. We used Differential Scanning 
Calorimetry (DSC) and Thermogravimetric Analysis (TGA) for the thermal characterization of 
this conjugate. DSC of the conjugate and PEG 2000 were performed at a ramp rate of 10ºC per 
minute at a temperature range of 25-200ºC to inspect the change in the Tg of the polymer and to 
assure the purity of the synthesized moiety. We also subjected the sample to TG analysis at the 




Determination of critical micellar concentration 
The design of the product suggests potential surfactant properties. These surface-active properties 
were confirmed using Tensiometry[24]. We used optical tensiometry to determine the surface 
tension of water at different surfactant concentrations. First the tensiometer was calibrated using a 
metallic calibration sphere for precision and the lens was adjusted to the highest resolution. 
Calibration of the lens was repeated after each sample. A range of concentrations (5, 10, 20, 50, 
100, 200, 300, 400, 500, 600, 700, 800, 1000, 1200 µg/ml) were used to determine the Critical 
Micellar Concentration of the final product. After the experiment, a graph of  Surface tension (γ) 
vs Log[Concentration]  was plotted. The point of CMC is considered as the end of the plateau 
formed by a sharp decline which is followed by a constant surface tension.  
Method of Analysis 
For the accurate and efficient estimation of Paclitaxel in this research project, Waters alliance 
e2695 HPLC separation module and Waters 2489 UV system was used using an existing High-
Performance Liquid Chromatographic method. The parameters for the used HPLC method are 
mentioned in the following table 2[10].  
Table 2. Parameters for HPLC detection 
Parameters Set values 
Mobile Phase ACN:WATER (45:55) 
Column LC-18-DB, Stainless steel, 250 mm X 4.6 
mm, 5µ particle size 
Injection volume 10 µl 
Detection wavelength  230 nm 





Run time 15 minutes 
 
Preparation of Paclitaxel loaded micelles 
Paclitaxel was the model drug selected for the formation of micelles because of its extremely 
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hydrophobic nature. The micelles were prepared by two methods (Co-solvent evaporation method 
and film hydration method) and the method with better encapsulation and loading efficiency was 
selected. For the co-solvent evaporation method, both the drug (1mg) and the polymer (30 mg 
POEM/200 mg Pluronic F127) were dissolved in 0.5 ml Acetonitrile. This solution was added drop 
by drop to 3 ml of water with constant stirring and this mixture was stirred for 2 hours. After two 
hours, this mixture was transferred to centrifuge tubes and exposed to centrifugation at 8000 RPM 
for 10 minutes. The supernatant containing micelles was collected and stored for further use[13][15]. 
For the film hydration method, both Paclitaxel (5 mg) and polymer (30 mg POEM/200 mg Pluronic 
F127) were dissolved in 2 ml of acetonitrile, this solution was stirred for 30 minutes and the ACN 
was evaporated using a Rotary vacuum evaporator forming a film at the bottom of the RBF. This 
film was hydrated by the drop by drop addition of DI water and the solution was stirred for 30 
minutes[10]. This solution was transferred to centrifuge tubes and exposed to centrifugation at 
13000 RPM for 10 minutes. The supernatant containing micelles was collected and stored in the 
dark for further use. 
Determination of the encapsulation and loading efficiency 
100 µl of the prepared micellar solution were further diluted with 1 ml of Acetonitrile and 
subjected to sonication for 10 minutes. This solution was then analyzed by a UV/VIS detector at 
230 nm using a Kinetex® 5µm EVO C18, 250 x 4.6 mm, 100Å HPLC column and ACN:Water  
(45:550) as the mobile phase. The loading and the encapsulation efficiencies were calculated using 





𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑙𝑜𝑎𝑑𝑒𝑑 𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑖𝑛 𝑚𝑔




𝐸𝑛𝑐𝑎𝑝𝑠𝑢𝑙𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) = (
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑙𝑜𝑎𝑑𝑒𝑑 𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑖𝑛 𝑚𝑔
𝐴𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑎𝑑𝑑𝑒𝑑 𝑃𝑎𝑐𝑙𝑖𝑡𝑎𝑥𝑒𝑙 𝑖𝑛 𝑚𝑔
) ∗ 100 
 
In vitro Release Testing 
The in vitro release testing was conducted for both Pluronic F127 and POEM based PTX loaded 
micelles using a dialysis bag. A 100-hour release study was performed for PTX loaded micelles 
prepared using Pluronic F127 and POEM. 1M Sodium Salicylate (pH 7.49) was used as a release 
medium as it acts as a hydrotropic moiety and enhances the solubility of PTX in water[10]. The 
prepared micelles were loaded in a cellulose bag (inertness of the bag was tested by incubating the 
bag in PTX solution and determining the concentration before and after) and immersed in the 
release media[10]. This setup was performed in two conditions i.e. in the dark and exposed to N-IR 
radiation. 1 ml sample was withdrawn at each timepoint which was replaced with 1 ml of fresh 
media to maintain sink conditions. The samples were estimated using HPLC. Plots of 









Chapter III: Results and discussion 
Structural characterization of the synthesized intermediates and final product   
 





Figure 7. 1H NMR of PEG-Linker, second and final product for the first part of the entire synthetic 
scheme. 
 
The Figure 6 shows the 1H NMR of activated Methoxy PEG which is the intermediate product for 
the synthesis of the first major reactant i.e. PEG-Linker (Methoxy Polyethylene glycol conjugated 
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with Octamethylene diamine). Figure 7 shows the 1H NMR of the first major reactant for the 


















Figure 11. 1H NMR of MB-EA-NP, second major reactant for the synthesis of the final product. 
Figure 9 and 10 show the 1H NMR of the first (MB-NP, activated Methylene Blue) and second 
(MB-EA, Methylene blue conjugated with Ethanolamine) intermediate products synthesized. 
Figure 11 shows the 1 HNMR of the second major reactant synthesized i.e. MB-EA-NP (activated 
MB-EA). Further, figure 12 shows the FT-IR spectrum of the final product. The NMR shows 
successful synthesis of all the intermediates and major reactants. 
 
 







Figure13. FT-IR of the final synthesized product (POEM). 
Figure 12 shows the 1H NMR of the final synthesized product. Further, Figure 13 shows the FT-
IR spectrum of the final product. From the FTIR, the functional groups present on POEM were 
confirmed. The NMR and FT-IR spectral analysis confirms the successful synthesis of POEM. 
Determination of light sensitivity by NIR irradiation 
 



































Each timepoint shows an increase in the absorbance of the Methylene Blue, this suggests that the 
methylene blue attached to the product is released on exposure to the N-IR radiation. On exposure 
of the sample concentration to the N-IR radiation over 30 minutes, the increase in absorbance 
ceases as seen in Figure 14 which shows complete release of methylene blue from the synthesized 
product. This experiment illustrated the N-IR sensitive nature of the synthesized product. 
 
Figure 15. MB release from POEM on exposure to UV radiation. 
Figure 15 shows the release of methylene blue on exposure to UV radiation. The increase in the 
absorbance of the polymeric solution exposed to the UV radiation at different timepoints can be 
clearly observed. This suggests and confirms the sensitivity of the synthesized product to UV 
irradiation. Further, the absorbance ceases to increase after 20 minutes. This suggests all the 






























Determination of sensitivity to ROS 
 
Figure 16. Sensitivity of POEM to hydroxyl free radicals produced by using Peroxidase enzyme. 
Sensitivity to ROS might further enhance the targeting provided by the synthesized polymer. This 
experiment was conducted to predict the sensitivity of the polymer to ROS. The polymer solution 
was exposed to hydrogen peroxide in the presence of Peroxidase (generates hydroxyl free radicals) 
which released the conjugated MB instantly as seen in Figure 16. This confirms the sensitivity of 
the polymer to the hydroxyl free radical in vitro. 
This hypothesis was further bolstered by exposing the polymeric solution to hydrogen peroxide 
which was converted to hydroxyl free radicals by Fe (II) ions. This is similar to the in vivo reaction 
catalyzed by the iron present in hemoglobin. As predicted, the polymer instantly released all the 
conjugated MB which could be visually observed by the color change in the polymeric solution 
from colorless to dark blue. This observation was further supported by the change in absorbance 
of the sample as displayed in Figure 17. The peak is similar to the polymer exposed to peroxide in 























Figure 17. Sensitivity of POEM to hydroxyl free radicals produced by using Fe(II) ion. 
Further the polymeric solution was exposed to peroxide solution for four days and the kinetics of 
MB release due to peroxide was compared with release due to hydrolysis. The increase in the 
absorbance was slow and gradual which confirmed that the polymer was more sensitive to 
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Figure 18. Sensitivity to Hydrogen Peroxide (Peroxide free radical). 
 
 
Figure 19. Sensitivity to Hydrolysis. 
 
From the comparative study of hydrolysis versus sensitivity to peroxide, it was observed that the 
initial rate of MB release was similar but after 24 hours the rate of release due to peroxide increased 
as compared to hydrolysis. At the end of day 3, the release was almost double as compared to 
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Figure 20. Comparison between rate of hydrolysis and sensitivity to Peroxide radical. 
 
Thermal characterization 
The DSC profile of the polymer revealed a decrease in the melting peak when compared with PEG 
2000. This reduction in the temperature of melting can be attributed to the inclusion of a big 
conjugate in the PEG structure. A plasticizer increases space between polymer molecules which 
reduces the temperature of melting of the given substance[27]. Attaching a large molecule like 
methylene blue using a linker might have increased the space between two PEG polymers which 
are closely stacked otherwise mimicking the activity of a plasticizer.  
 
Figure 21.DSC overlay of MB, POEM and PEG 2000. 
 
The TGA profile of the polymer did not show any degradation up to 200 ºC. This suggests one of 
the two things. Firstly, the polymer is thermostable up to 200 ºC or the degradation or breakdown 
of the polymer is not leading to a decline in the weight of the molecule (no volatile degradant 
present). The first assumption is supported by the observation that no degradation peaks are visible 
in the DSC profile. This suggests that the polymer is thermo-stable and can be subjected to high 
temperature during formulation of a drug delivery platform.
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Determination of critical micellar concentration (CMC) 
 
Figure 22. Critical Micellar Concentration (CMC) determination using tensiometry, plot of 
Surface tension versus Log of Concentration. 
 
A plot of surface tension versus log of concentration was plotted to determine the surface tension 
of the synthesized surfactant. The point of sharp decline was determined and considered as the 
CMC of the surfactant[26]. 
Table 3. Observations of surface tension for various concentrations of synthesized polymer.  
Concentration (mg/ml) Log of Concentration Surface tension 
1E-6 -6.00 72.83±1.88 
5E-5 -4.30 72.64±1.23 
1E-4 -4.00 72.32±0.70 
5E-4 -3.30 72.06±0.89 
1E-3 -3.00 71.71±2.17 
2.5E-2 -1.60 64.32±1.38 
5E-2 -1.30 61.94±0.82 
0.1 -1.00 60.57±0.72 
0.25 -0.60 58.55±0.77 
0.5 -0.30 57.44±0.96 
1 0.00 56.63±1.07 
2 0.30 55.09±0.75 
2.5 0.39 55.14±1.87 
4 0.60 55.67±1.07 
5 0.69 55.74±1.24 






















10 1 55.9±0.7 
From the plot and the values, the CMC was found to be 250 g/ml for the synthesized surfactant.  
It can be observed that the surface tension after the CMC was constant which shows that all the 
unbalanced surface charge responsible for the surface tension of water was balanced by the 
surfactant. The CMC can be used to determine the amount of polymer required to encapsulate the 
model drug used in this research project. Furthermore, the concentration on polymer should be 
maintained over CMC to ensure maximum encapsulation of the drug in the polymeric core. The 
reduction of surface tension to 55 dynes/cm3 also shows that the polymer synthesized is not a very 
powerful surfactant. This might delay the rate of self-assembly and micelle formation, hence 
selection of an efficient method for the preparation of micelles is crucial. 
Determination of the encapsulation and loading efficiency of paclitaxel loaded micelles 
The encapsulation and loading efficiencies were determined using the calibration curve of PTX 
taking 5,10,20,40 and 80 µg/ml concentrations. The calibration curve formed had an R2 of 0.999 
and hence was used for estimation of PTX loaded in the micelles. The encapsulation and loading 
efficiencies of POEM and Pluronic F127 are provided in Table 4.  
Table 4. Summary of encapsulation and loading efficiency for POEM and Pluronic F127 
Method of 
preparation 

























5 07.63±0.10 0.0019±0.000028 
 
 
It can be seen that the film hydration method provided a better and higher encapsulation efficiency 
26 
 
as compared to the co solvent evaporation method for POEM. This could be attributed to the design 
of the preparation method as the slow evaporation of ACN provides sufficient time to the polymer 
for self-assembly (micelle formation) and the drug is already incorporated in the polymeric matrix 
during the hydration of film. This facilitates the encapsulation of drug in the micellar core. In 
contrast to the film hydration method, co-solvent evaporation does not provide enough time for 
the formation of micelles as the organic phase is added to the aqueous phase and due to the sudden 
change in the environment majority of the API gets precipitated out. Only the drug present in close 
vicinity to the polymeric clusters are stabilized in the micellar core which results in lower 
encapsulation of the API. 
In vitro Release Testing Studies 
 
Figure 22. in vitro release profiles of PTX loaded P-F127 and POEM based micelles. 
The membrane was found to be inert and absorbed only 299 ng of drug from the solution which 
was insignificant as compared to the loaded drug amount. The in vitro release studies performed 
in dark showed a constant gradual increase in the concentration of PTX from both P-F127 and 
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to hydrolysis of the polymer but as seen in the studies conducted above, the rate of hydrolysis is 
and should be further hindered due to the micellar aggregation of the polymer as the MB part forms 
the hydrophobic core stabilizing the urea bond from instant hydrolysis. This confirms our 
hypothesis that the drug will not be released completely from the self-assembled nanoparticle 
unless exposed to an external stimulus (N-IR, UV or ROS). 
 
Figure 23. in vitro release profiles of PTX loaded P-F127 and POEM based micelles. 
The above-mentioned claim was supported by the burst release of PTX observed when the release 
assembly was exposed to N-IR radiation after keeping it protected from light for the first hour of 
the experiment. This burst release of the drug on exposure to N-IR stimuli can be confirmed from 
this experiment. Furthermore, P-F127 which was used as a control for this experiment displayed 
insignificant difference between the two experimental conditions. This confirmed that the release 
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CHAPTER IV: CONCLUSION 
Cancer targeting is slowly becoming an important aspect of cancer chemotherapy because of the 
severe side effects observed in conventional chemotherapy. The objective of synthesizing a novel 
light sensitive, self-assembling polymer for the potential targeted delivery of chemotherapeutic 
agents was successfully performed. Synthesis and structural characterization of all the 
intermediates and the final product were performed and interpreted successfully. Furthermore, the 
sensitivity of the synthesized polymeric entity towards N-IR, UV and ROS were depicted through 
in vitro experimental models. The surface-active property and thermal characteristics of the 
polymer were investigated and reported successfully. Based on the CMC, PTX was successfully 
loaded into POEM based micelles. Release studies to confirm the release of PTX on exposure to 
N-IR irradiation were successfully conducted and the burst release of PTX from the micelles on 
exposure to stimuli was confirmed with the in vitro release studies. From the experimentation and 
characterization performed, it can be concluded that POEM is a light sensitive, surface active 
polymeric entity with self-aggregating properties which can be used to develop a targeted 
nanoparticulate drug delivery platform. Further studies such as ex vivo cell viability assays, 
cytotoxicity assays using cell lines and in vivo studies on animal models should be performed after 
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